跳至主要内容
临床试验/NL-OMON55656
NL-OMON55656招募中2 期

GLP-1 receptor expression and beta-cell mass in patients with type 2 diabetes - GLP1R-T2D

Radboud Universitair Medisch Centrum0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Scheduled for partial or complete pancreatectomy at Radboudumc

排除标准

  • 1.. Breast feeding, 2. Pregnancy or the wish to become pregnant within 6
  • months, 3. Creatinine clearance below 40ml/min, 4. Age > 18 years, 5. Liver
  • disease defined as aspartate aminotransferase or alanine aminotransferase level
  • of more than three times the upper limit of normal range, 6. Previous treatment
  • with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV
  • inhibitors in the past 3 months

研究者

相似试验